Conrad-Amadeus Voltin

9PUBLICATIONS
26CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Environmental studies in animal productionInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 19, 2023
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.

Conrad-Amadeus Voltin, Andrea Paccagnella, Michael Winkelmann

|Feb 25, 2022
Influences on PET Quantification and Interpretation.

Julian M M Rogasch, Frank Hofheinz, Lutz van Heek

|Oct 30, 2020
Early Response to First-Line Anti-PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial.

Conrad-Amadeus Voltin, Jasmin Mettler, Lutz van Heek

|Sep 01, 2018
Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma.

Carsten Kobe, Helen Goergen, Christian Baues

Pageof 2